PAI-1 Inhibitor TM5441 Attenuates Emphysema and Airway Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease
International Journal of Molecular Sciences · 23.07.2025 · 26 (15) · 7086
DOI: 10.3390/ijms26157086 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.07.2025. Verfasst von Kyohei Oishi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu 431-3192, Japan. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Plasminogen Activator Inhibitor 1, Pulmonary Emphysema. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Themen: COPD
Abstract (Originalsprache)
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide, primarily driven by chronic airway inflammation due to cigarette smoke exposure. Despite its burden, however, current anti-inflammatory therapies offer limited efficacy in preventing disease progression. Plasminogen activator inhibitor-1 (PAI-1), as a key regulator of fibrinolysis, has recently been implicated in structural airway changes and persistent inflammation in patients with COPD. This study aimed to investigate the ability of the PAI-1 inhibitor TM5441 to attenuate airway inflammation and structural lung damage induced by a cigarette smoke extract (CSE) in a mouse model. Mice received intratracheal CSE or vehicle on days 1, 8, and 15, and were sacrificed on day 22. TM5441 (20 mg/kg) was administered orally from days 1 to 22. The CSE significantly increased the mean linear intercept, destructive index, airway resistance, and reductions in dynamic compliance. The CSE also increased the numbers of neutrophils and macrophages in the bronchoalveolar lavage fluid, systemic PAI-1 activity, and neutrophil elastase mRNA and protein expression in the lungs. TM5441 treatment significantly suppressed these changes without affecting coagulation time. These findings suggest that TM5441 may be a novel therapeutic agent for COPD by targeting PAI-1-mediated airway inflammation and emphysema.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu 431-3192, Japan.
- Center for Clinical Research, Hamamatsu University Hospital, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu 431-3192, Japan.
- Department of Pharmaceutical Sciences, School of Pharmacy at Narita, International University of Health and Welfare, 4-3, Kozunomori, Narita 286-8686, Japan.
- Department of Pharmacology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu 431-3192, Japan.
- Department of Medical Physiology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu 431-3192, Japan.
- Department of Molecular Medicine and Therapy, Tohoku University School of Medicine, 2-1 Seiryo-Machi, Aoba-ku, Sendai 980-8575, Japan.
ORCID-Profile: Kyohei Oishi, Hideki Yasui, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Takayuki Iwaki, Yuko Suzuki
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Oishi, K., Yasui, H., Inoue, Y., Hozumi, H., Suzuki, Y., Karayama, M., Furuhashi, K., Enomoto, N., Fujisawa, T., Horinouchi, T., Iwaki, T., Suzuki, Y., Miyata, T., Inui, N., & Suda, T. (2025). PAI-1 Inhibitor TM5441 Attenuates Emphysema and Airway Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences, 26(15), 7086. https://doi.org/10.3390/ijms26157086
Vancouver
Oishi K, Yasui H, Inoue Y, Hozumi H, Suzuki Y, Karayama M, et al. PAI-1 Inhibitor TM5441 Attenuates Emphysema and Airway Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences. 2025;26(15):7086. doi:10.3390/ijms26157086
BibTeX
@article{Oishi2025,
author = {Oishi, Kyohei and Yasui, Hideki and Inoue, Yusuke and Hozumi, Hironao and Suzuki, Yuzo and Karayama, Masato and Furuhashi, Kazuki and Enomoto, Noriyuki and Fujisawa, Tomoyuki and Horinouchi, Takahiro and Iwaki, Takayuki and Suzuki, Yuko and Miyata, Toshio and Inui, Naoki and Suda, Takafumi},
title = {PAI-1 Inhibitor TM5441 Attenuates Emphysema and Airway Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {15},
pages = {7086},
doi = {10.3390/ijms26157086}
}
EUVIMED